KWM advises China Molybdenum on two landmark acquisitions totalling over US $4.1 billion

KWM advises China Molybdenum on landmark acquisitions

News

King & Wood Mallesons advises China Molybdenum on two landmark acquisitions totalling over US $4.1 billion

KWM has continued to support long-term client CMOC on its global expansion, advising on the two largest mining acquisitions by a Chinese company.

17 May 2016

EU companies less inclined to do business with the UK in the result of Brexit

European business leaders predict that a Brexit would adversely affect their business and claim that the UK should be ‘punished’ if it votes to leave, according to a...

11 May 2016

King & Wood Mallesons advises UBS Wealth Management on $471 Million Oncology Impact Fund

King & Wood Mallesons has advised UBS on the final closing of its $471 million Oncology Impact Fund, which is aimed at developing cancer treatments.

28 April 2016

King & Wood Mallesons launches joint report on Cross-Border RMB Market

This report highlights the channels that are available and new initiatives that are underway in the cross-border RMB market.

27 April 2016

King & Wood Mallesons advises Lonsdale Capital Partners LLP on the close of its £110 million fund

KWM has advised Lonsdale Capital Partners LLP on the close of its first fund at its target and hard-cap amount of £110 million

19 April 2016

King & Wood Mallesons bolsters London Capital Markets offering with new partner Greg Stonefield

KWM has continued to bolster its capital markets and London Corporate practice with the addition of senior M&A and ECM specialist Greg Stonefield

22 March 2016